TipRanks on MSN5d
Lumos Pharma Faces Uncertainty as CVRs Risk Expiring Worthless Post-Merger
Lumos Pharma, Inc. (LUMO) has disclosed a new risk, in the Share Price & Shareholder Rights category. Lumos Pharma, Inc. faces a significant risk ...
Pineapple Energy Announces Distribution to Contingent Value Rights Holders
Our new leadership team continues to author a new future for Pineapple Energy, with a focus on elevating our corporate governance, properly aligning our cost structure, creating a new corporate ...
Pineapple Energy announces 35c distribution to CVR holders
Pineapple Energy (PEGY) will distribute to the holders of its non-transferable Contingent Value Rights a payment of $850,269, or $0.35 per CVR.
Cartesian Therapeutics: Uncertainty Remains
Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...
Business Wire7d
Core Scientific Announces Fiscal Third Quarter 2024 Results
Total revenue for the fiscal third quarter of 2024 was $95.4 million, and consisted of $68.1 million in Digital asset ...
Nasdaq5d
Lumos Pharma Faces Uncertainty as CVRs Risk Expiring Worthless Post-Merger
Lumos Pharma, Inc. faces a significant risk concerning the potential valueless expiration of the Contingent Value Rights (CVRs) offered to stockholders post-2024 Merger and Offer completion.